Annual conference Sydney 2-3 Aug 2008

  • 02 Aug 2008
  • 8:30 AM
  • 03 Aug 2008
  • 5:30 PM
  • Sydney

Registration

  • This concession fee is payable by Fellow, Student and Partner members whose partner has registered for the conference
  • This concession fee is payable by Fellow, Student and Partner members whose partner has registered for the conference
  • This fee is payable by full, associate and corporate members
  • This fee is payable by full, associate and corporate members
  • This fee is payable by non-members wishing to attend the conference
  • This fee is payable by non-members wishing to attend the conference
  • Only for speakers at the conference

Registration is closed
End Time: 17.00
2nd ANSA Annual Conference Sydney
Descriptions abbreviated - Full details at
http://www.ansa.au.com

Speakers

Dr. Tom Collura PhD

Title: Overview of Z score Neurofeedback training, 4-channel
designs and 4 channel MINI-Q assessment and training
Dr Collura will present an overview of how Z score training eliminates
the hit and miss of knowing what to train and for how-long, on
account of the trained measure being continuously compared those
of to a normative database. In addition Dr Collura will introduce the
concept of EEG archetypes based on 4-channel Mini-QEEG for
assessment  and 4 channel montages for Neurofeedback. These
concepts will be more fully discussed with implementation protocols
in the pre-conference workshop.

Dr. Donald Moss PhD

Title: User-Friendly Mind-Body Therapies for Health Care
Increasingly, patients suffer from disorders produced by exposure to
stressful environments and by maladaptive life styles that dispose
one to illness. Mind-body therapies reverse the effects of the human
stress response and moderate the symptoms of many common
medical disorders. Mind-body approaches provide useful adjuncts to
mainstream medical care. In many cases fairly minimal
interventions, of brief duration, can make significant differences in
the patient’s symptoms and quality of life. Dr Moss will identify a
wide range of medical diseases and conditions, for which such
mind-body interventions have demonstrated effectiveness.


Dr Rien Breteler, PhD
Title: Brain Processes in Dyslexia and their Consequences for
Neurofeedback: A Review of Current Developments and Future
Directions. 

About 15% of the population differs from normals in reading and
writing ability due to dyslexia, a specific disorder in the language
system. The phonological deficit theory concerning decoding and
identification of text has received most support. A “dyslexic triad”
has been postulated consisting of poor phonological awareness,
poor verbal short-term memory and slow lexical retrieval. Recent
research suggests the importance of memory load, explaining why
most children with dyslexia can correctly repeat one- and
two-syllable nonwords. QEEG-guided neurofeedback, addressing the
left occipito-temporal word form area during reading, and coherence
may be one of the most promising interventions for dyslexia of the
current century.

Professor Richard Silberstein PhD
Title: Creativity, Dopamine and Attention Deficit Hyperactivity
Disorder.
Attention Deficit Hyperactivity Disorder (ADHD) is the most commonly
diagnosed paediatric neuropsychiatric disorder.  Genetic factors
appear to play a significant role in the incidence of ADHD and
specific variations in the dopamine 4 receptor (DR4) have been
associated with the diagnosis of ADHD and attention deficit disorder
(ADD).  While ADHD and ADD are most commonly considered a
disorder or a cognitive deficit, there is growing evidence that ADD
and ADHD traits confer an adaptive advantage for individuals in
hunter gatherer societies.  More recent research has also suggested
a relationship between ADHD and creativity.  In this presentation I
will explore the relationship between ADHD and creativity in the
context of the neural mechanisms modulation brain functional
connectivity.

Dr Stephanie Fryar-Williams MBBS BSc FRANZCP.
Title: New Biomarkers May Predict Mental Illness Diagnosis.
Dr Williams will present the findings of a 2007 Biomarker pilot study
(80 patients and 20 controls) on patient populations with
schizophrenia and other mental illness conditions, with particular
emphasis on mental illness preventative strategies.

Through strategic screening tests accross these relevant biochemical
pathways  it may now be possible to predict the likelihood of mental
illness occurring, predict the likelihood of medication response, as
well as assess prognosis and likely future disability.  Statistical
analysis of biomarkers within a patient population during 2007
revealed.


Dr Chris Millar MBBS
Title: Biofeedback in General Practice.
The psychophysiological basis of biofeedback makes it an ideal
modality for medically trained clinicians. The nature of everyday
general practice work is such that it provides a ready supply of
problems with potential biofeedback solutions: in particular,
depression, anxiety, stress, and insomnia. Combined with nutritional
and lifestyle advice it offers an effective and vital middle way
between supportive counselling/CBT and medication/surgery. Five
years of experience integrating biofeedback (EEG and HRV) into
mainstream general practice will be presented.

Dr Angelo Schibeci, BA (Hons Psych), BSc, MSc, PhD, MAPS,
MANSA                                                                                                                                                               Title: QEEG features and neurofeedback treatment in Asperger’s
Syndrome.  
Although patients with Aspergers syndrome present with
heterogeneous EEG profiles, it appears that certain regions of the
brain show common impairments. Nonetheless, Neurofeedback has
been demonstrated to be a successful intervention in the treatment
of this disorder. Statistically significant changes before and after
neurofeedback treatment have been demonstrated in the QEEG.
These changes have been correlated with positive outcomes in
objective measures.

Nerida Saunders, BA, Dip Ed, Graduate Dip Coun, M Phil.
Title: International Study investigating the efficacy of
neurofeedback (NF) on brain function, cognitive performance,
clinical symptomatology and behavior in 500 AD/HD subjects.
The International Study of Attention-Deficit/Hyperactivity Disorder
Neurofeedback Efficacy (iSANE) will investigate the efficacy of
neurofeedback (NF) on electroencephalographic (EEG) brain function,
cognitive performance, clinical symptomatology and behavior in 500
ADHD subjects. The trial protocol has been established according to
CONSORT (Consolidated Standards of Reporting Trials) guidelines.

Jacques Duff: BA Psych, Grad Dip Psych. 
Title: QEEG, Anxiety and intestinal overgrowth of Streptococcus.
There is much evidence suggesting that Irritable Bowel Syndrome
(IBS) is asociated with intestinal dysbiosis (abnormal distribution of
comensal bacteria). There is also evidence that around 70-90% of
people with IBS report a psychiatric disorder, mostly anxiety and
depression. We present evidence that anxiety and panic disorder is
frequently associated with an overgrowth of streptococcus measured
with faecal microbiology analysis (FMA).
 

Dr Paul Mahoney BEd, DPsych Sport & Exercise Psychologist
Title: EEG assessment and Neurofeedback applied in a sporting
context. 
EEG activity and Neurofeedback has been used in a variety of ways
to enhance performance. This presentation will outline the dynamic
use of EEG assessments and Neurofeedback techniques for
performance enhancement. Much of the research suggests that
associations between EEG activity and sporting performance reflect a
large amount of individual difference. It follows that Neurofeedback
interventions would be more effective if they were tailored to the
specific needs of the individual and their own performance. A
number of assessment strategies that aim to individualise the
intervention will be described. In particular a QEEG assessment will
be compared to the use of only one or two channels.

Mirjana Askovic and Sejla Tukelija,
Title: Neurofeedback Therapy in Work with Complex Trauma
Focusing on Affect Dysregulation
This presentation will cover STARTTS experiences in using
neurofeedback with clients suffering complex trauma. The paper will
address the theoretical underpinning of working with complex
trauma, particularly focusing on issues of affect dysregulation. A
detailed case study of a 14 years old African boy will illustrate the
practical application of neurofeedback training in resolving
longstanding issues of severe anger and impulse control.

Plus other presentations by
Dr Donald Moss,
Dr Rien Breteler,
Dr Donald Rowe
Titles to be announced.

Panel Discussions after lunch
1. Approaches to neurofeedback & future direction (Saturday)
2. Accreditation (discussion of proposed models)
(Sunday)

Upcoming events

Recent forum updates

  • There are no forum topics to display.

Copyright © 2017 Applied Neuroscience Society of Australasia.
Powered by Wild Apricot Membership Software